For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Gangagen, Inc.

USPTO Granted Patents = 13

% Expired Patents = 15.4

EPO Patents = 4

Forward Citations = 62

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Bharathi Sriram (13 out of 13 patents)

Sriram Padmanabhan (10 out of 12 patents)

R Sanjeev Saravanan (5 out of 7 patents)

4. Janakiraman Ramachandran (5 out of 7 patents)

5. Vivek Daniel Paul (4 out of 7 patents)

6. Chemira B Appaiah (2 out of 4 patents)

7. C B Appaiah (2 out of 2 patents)

8. Jayasheela Manur (1 out of 1 patent)

9. R Sanjeev Saravana (1 out of 1 patent)

10. Padmanabhan Sriram (1 out of 1 patent)

11. Jayashella Manur (1 out of 1 patent)

12. Cb Appaiah (0 patent)

13. M Jayasheela (0 patent)

13 patents: Sort by Forward Citations

1. 10278398 - Phage derived antimicrobial activities (2019-05-07),

2. 10092608 - Reducing conjugative plasmids in bacteria (2018-10-09),

3. 9932569 - Chimeric antibacterial polypeptides (2018-04-03),

4. 9801930 - Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression (2017-10-31),

5. 9622486 - Phage derived antimicrobial activities (2017-04-18),

6. 9605250 - Chimeric antibacterial polypeptides (2017-03-28),

7. 9289481 - Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression (2016-03-22),

8. 9193946 - Reducing conjugative plasmids in bacteria (2015-11-24),

9. 8748150 - Phage derived antimicrobial activities (2014-06-10),

10. 8202516 - Phage derived antimicrobial activities (2012-06-19),

11. 7087226 - Lysin-deficient bacteriophages having reduced immunogenicity (2006-08-08),

12. 6913753 - Incapacitated whole-cell immunogenic bacterial compositions (2005-07-05),

13. 6896882 - Lysin-deficient bacteriophages having reduced immunogenicity (2005-05-24),

GangaGen, Inc. is a biotechnology company specializing in the development of novel phage-based products for combating bacterial infections. With a focus on precision medicine, GangaGen aims to address the urgent need for new antimicrobial agents to tackle drug-resistant pathogens. Through innovative research and cutting-edge technologies, the company strives to improve patient outcomes and reduce the global burden of infectious diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#31 in Newark, CA

#5,648 in California

#23,808 in US

#44,950 in the World

Newark, CA, United States of America

Gangagen, Inc.

Forward Citations = 62

11 inventors:

Bharathi Sriram (13 out of 13 patents)

Sriram Padmanabhan (10 out of 12 patents)

R Sanjeev Saravanan (5 out of 7 patents)

4. Janakiraman Ramachandran (5 out of 7 patents)

5. Vivek Daniel Paul (4 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…